Company Encyclopedia
View More
name
Jasper Therapeutics - CW26
JSPRW.US
News
View More

Jasper Therapeutics - CW26 | 10-Q: FY2025 Q3 Revenue: USD 0

LB filings·
US
JSPRW
-13.04%
LB filings·
US
JSPRW
-13.04%

Jasper Therapeutics - CW26 | 8-K: FY2025 Q3 Revenue: USD 0

LB filings·
US
JSPRW
-13.04%
LB filings·
US
JSPRW
-13.04%

Jasper Therapeutics - CW26 | 8-K: FY2025 Q2 EPS: USD -1.74

LB filings·
US
JSPRW
-13.04%
LB filings·
US
JSPRW
-13.04%

Jasper Therapeutics - CW26 | 10-Q: FY2025 Q2 EPS: USD -1.74

LB filings·
US
JSPRW
-13.04%
LB filings·
US
JSPRW
-13.04%

Jasper Therapeutics - CW26 | 10-Q: FY2025 Q1 EPS: USD -1.41

LB filings·
US
JSPRW
-13.04%
LB filings·
US
JSPRW
-13.04%
© 2025 Longbridge｜Disclaimer